The Iliac/SFA/Popliteal Center

Filter Your Results




PQ Bypass Receives IDE to Initiate DETOUR II Pivotal Trial

December 13, 2017 -- PQ Bypass, Inc. announced it has received conditional approval of its investigational device exemption from the US Food and Drug Administration to initiat…

Twelve-Month ILLUMENATE Global Study Results Published for the Stellarex DCB

December 11, 2017 -- The final 12-month results from the ILLUMENATE Global study were published by Herman Schroë, MD, et al online ahead of print in Catheterization and C…

Vascular Flow Technologies Partners With Biovic to Develop Avatar Spiral Laminar Flow Graft

November 29, 2017 -- Vascular Flow Technologies (VFT), a United Kingdom-based developer of spiral laminar flow (SLF) technology, recently announced the successful conclusion o…

Cagent Vascular’s Serrantor Alto PTA Serration Balloon Catheter Receives CE Mark

November 21, 2017 -- Cagent Vascular announced that its Serranator Alto PTA serration balloon catheter has received CE Mark approval. The Serranator Alto, which received FD…

Trial Subanalysis Finds Empagliflozin Can Reduce Risk of Cardiovascular Death in Patients With Type 2 Diabetes and PAD

November 21, 2017 -- Data from the EMPA-REG OUTCOME trial showed that empagliflozin reduced the risk of cardiovascular death compared with placebo when added to standard of ca…

Network Meta-Analysis Evaluates Endovascular Interventions for Femoropopliteal Disease

November 8, 2017 -- Findings from a study using network meta-analysis (NMA) to determine the optimal endovascular strategy for managing femoropopliteal peripheral artery disea…

SHIELD Trial Results Announced for Symic Bio's SB-030 in Peripheral Vascular Disease

November 1, 2017 -- Symic Bio announced results from the phase 1/2 SHIELD trial evaluating SB-030, a locally administered therapeutic, in patients with peripheral vascular dis…

TRANSCEND Pivotal Clinical Trial Commences for Surmodics' SurVeil DCB

November 2, 2017 -- Surmodics, Inc. announced enrollment of the first patient in TRANSCEND, the pivotal clinical trial for the company's SurVeil drug-coated balloon (DCB).…




Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.